These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25384261)

  • 1. Rates of psychotropic medication use reported by borderline patients and axis II comparison subjects over 16 years of prospective follow-up.
    Zanarini MC; Frankenburg FR; Bradford Reich D; Harned AL; Fitzmaurice GM
    J Clin Psychopharmacol; 2015 Feb; 35(1):63-7. PubMed ID: 25384261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission.
    Zanarini MC; Frankenburg FR; Hennen J; Reich DB; Silk KR
    Am J Psychiatry; 2004 Nov; 161(11):2108-14. PubMed ID: 15514413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro re nata (as needed) psychotropic medication use in patients with borderline personality disorder and subjects with other personality disorders over 14 years of prospective follow-up.
    Martinho E; Fitzmaurice GM; Frankenburg FR; Zanarini MC
    J Clin Psychopharmacol; 2014 Aug; 34(4):499-503. PubMed ID: 24875066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult experiences of abuse reported by borderline patients and Axis II comparison subjects over six years of prospective follow-up.
    Zanarini MC; Frankenburg FR; Reich DB; Hennen J; Silk KR
    J Nerv Ment Dis; 2005 Jun; 193(6):412-6. PubMed ID: 15920382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The longitudinal course of borderline psychopathology: 6-year prospective follow-up of the phenomenology of borderline personality disorder.
    Zanarini MC; Frankenburg FR; Hennen J; Silk KR
    Am J Psychiatry; 2003 Feb; 160(2):274-83. PubMed ID: 12562573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial functioning of borderline patients and axis II comparison subjects followed prospectively for six years.
    Zanarini MC; Frankenburg FR; Hennen J; Reich DB; Silk KR
    J Pers Disord; 2005 Feb; 19(1):19-29. PubMed ID: 15899718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidenced-based pharmacologic treatment of borderline personality disorder: a shift from SSRIs to anticonvulsants and atypical antipsychotics?
    Abraham PF; Calabrese JR
    J Affect Disord; 2008 Nov; 111(1):21-30. PubMed ID: 18304647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The subsyndromal phenomenology of borderline personality disorder: a 10-year follow-up study.
    Zanarini MC; Frankenburg FR; Reich DB; Silk KR; Hudson JI; McSweeney LB
    Am J Psychiatry; 2007 Jun; 164(6):929-35. PubMed ID: 17541053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluidity of the Subsyndromal Phenomenology of Borderline Personality Disorder Over 16 Years of Prospective Follow-Up.
    Zanarini MC; Frankenburg FR; Reich DB; Fitzmaurice GM
    Am J Psychiatry; 2016 Jul; 173(7):688-94. PubMed ID: 26869248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mental health service utilization by borderline personality disorder patients and Axis II comparison subjects followed prospectively for 6 years.
    Zanarini MC; Frankenburg FR; Hennen J; Silk KR
    J Clin Psychiatry; 2004 Jan; 65(1):28-36. PubMed ID: 14744165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axis II comorbidity of borderline personality disorder: description of 6-year course and prediction to time-to-remission.
    Zanarini MC; Frankenburg FR; Vujanovic AA; Hennen J; Reich DB; Silk KR
    Acta Psychiatr Scand; 2004 Dec; 110(6):416-20. PubMed ID: 15521825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological treatment of borderline personality disorder: a retrospective observational study at inpatient unit in Italy.
    Paolini E; Mezzetti FA; Pierri F; Moretti P
    Int J Psychiatry Clin Pract; 2017 Mar; 21(1):75-79. PubMed ID: 27669762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy of borderline personality disorder: what has changed over two decades? A retrospective evaluation of clinical practice.
    Timäus C; Meiser M; Bandelow B; Engel KR; Paschke AM; Wiltfang J; Wedekind D
    BMC Psychiatry; 2019 Dec; 19(1):393. PubMed ID: 31830934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: A comparison with other psychiatric disorders.
    Bridler R; Häberle A; Müller ST; Cattapan K; Grohmann R; Toto S; Kasper S; Greil W
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):763-72. PubMed ID: 25907249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Psychopharmacotherapy in adolescents with borderline personality disorder in inpatient and outpatient psychiatric treatment].
    Wöckel L; Goth K; Matic N; Zepf FD; Holtmann M; Poustka F
    Z Kinder Jugendpsychiatr Psychother; 2010 Jan; 38(1):37-49. PubMed ID: 20047175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of prescription opioid medication by patients with borderline personality disorder and axis II comparison subjects: a 10-year follow-up study.
    Frankenburg FR; Fitzmaurice GM; Zanarini MC
    J Clin Psychiatry; 2014 Apr; 75(4):357-61. PubMed ID: 24500123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic management of bipolar disorder in France and Europe: a multinational longitudinal study (WAVE-bd)].
    Bellivier F; Delavest M; Coulomb S; Figueira ML; Langosch JM; Souery D; Vieta E
    Encephale; 2014 Oct; 40(5):392-400. PubMed ID: 25238903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychotropic use in community residential care facilities: A prospective cohort study.
    Lakey SL; Gray SL; Sales AE; Sullivan J; Hedrick SC
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):227-35. PubMed ID: 17062323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Borderline personality and psychotropic medication prescription in an outpatient psychiatry clinic.
    Sansone RA; Rytwinski D; Gaither GA
    Compr Psychiatry; 2003; 44(6):454-8. PubMed ID: 14610722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.